Related Experiment Video

Updated: Jun 1, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

AOPPs inhibits cholesterol efflux by down-regulating ABCA1 expression in a JAK/STAT signaling pathway-dependent

Zhong-Cheng Mo1, Ji Xiao, Xie-Hong Liu

  • 1Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Life Science Research Center, University of South China, Hengyang, China.

Journal of Atherosclerosis and Thrombosis
|June 15, 2011
PubMed
Abstract

Insights

Advanced oxidation protein products (AOPPs) reduce cholesterol efflux from macrophage foam cells by decreasing ABCA1 and LXRα expression via the JAK/STAT pathway. This finding is crucial for understanding atherosclerosis pathogenesis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cardiovascular Research

Background:

  • Advanced oxidation protein products (AOPPs) are emerging risk factors for coronary artery disease.
  • Macrophage foam cells play a critical role in the development of atherosclerosis.

Purpose of the Study:

  • To investigate the effects of AOPPs on cholesterol efflux from human macrophage foam cells.
  • To elucidate the underlying molecular mechanisms involved in AOPPs-mediated cholesterol dysregulation.

Main Methods:

  • THP-1 monocytes were differentiated into foam cells using PMA and ox-LDL.
  • Protein and mRNA expression levels of key genes were analyzed using western immunoblotting and qPCR.
  • Cellular cholesterol content and efflux were quantified using HPLC and liquid scintillation counting, respectively.

Main Results:

  • AOPPs significantly reduced cholesterol efflux and downregulated the expression of ABCA1 and LXRα in foam cells.
  • AOPPs activated NADPH oxidase and the JAK/STAT signaling pathway.
  • Inhibition of NADPH oxidase or JAK/STAT signaling abolished the detrimental effects of AOPPs on cholesterol efflux and ABCA1 expression.

Conclusions:

  • AOPPs inhibit cholesterol efflux by downregulating LXRα and ABCA1 expression, primarily through the activation of the JAK/STAT pathway.
  • These findings provide insights into the role of AOPPs in atherosclerosis pathogenesis and suggest potential therapeutic targets.

More Related Videos

High-Density Lipoprotein-Specific Phospholipid Efflux Assay07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...